TOBRAMYCIN + DEXAMETHASONE eye drops suspension

Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Allergic Conjunctivitis Innovator: Opatanol (Alcon)

Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex)

Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)

Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)

Strength: 0.088 mg/tab; 0.18 mg/tab; 0.35 mg/tab; 0.7 mg/tab Therapeutic area: Idiopathic Parkinson's Disease & Idiopathic restless legs syndrome Innovator: Mirapexin (Boehringer Ingelheim)

Strength: 20 mg/ml Presentation: vials, 5 ml & 10 ml Therapeutic area: Relief and treatment of seasonal and perennial allergic conjunctivitis Innovator: Opticrom (Sanofi)

Strength: (40 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: DuoTrav (Alcon-Novartis)

Strength: 40 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Travatan (Alcon-Novartis)

Strength: 4 mg/5 ml Presentation: vials, 5 ml Therapeutic area: Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia Innovator: Zometa (Novartis)

Strength: 5 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Events Innovator: Crestor (AstraZeneca)

 Strength: 3 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Infections Innovator: Tobrex (Alcon)

Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Conjunctivitis Innovator: Moxivig (Novartis)